ATS Corporation announced that its Interim Chief Financial Officer, Anne Cybulski, and Group Executive for Life Sciences, Sarah Moore, will participate in the Jefferies Industrials Conference in New York City on September 10, 2026, hosting a fireside chat at 12:10 p.m. ET. The company also provided an update on its normal course issuer bid, reporting that through August it purchased 1,119,413 shares at an average price of $27.97 per share, including 146,085 shares previously disclosed. Under the NCIB, which runs from December 22, 2025, to December 21, 2026, ATS can purchase up to 8,225,621 shares for cancellation, and management expects to remain active in the program as part of its capital allocation strategy.
ATS CorporationCompany updates share buyback program, indicating ongoing capital allocation and potential support for share price.
